Alsuma FDA Approval History
FDA Approved: Yes (Discontinued) (First approved June 29, 2010)
Brand name: Alsuma
Generic name: sumatriptan
Dosage form: Injection
Company: King Pharmaceuticals, Inc.
Treatment for: Migraine, Chronic Migraine, Cluster Headaches
Marketing Status: Discontinued
Alsuma (sumatriptan injection) is a triptan indicated for the acute treatment of migraine attacks and cluster headache episodes.
Development Timeline for Alsuma
|Jul 7, 2010||FDA Approves Alsuma Auto-Injector|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.